Skip to main content
NM

NuGen Medical Devices

NuGen Medical Devices develops needle-free drug delivery technologies that eliminate the need for traditional needles, enhancing patient comfort and compliance. Their products are designed to improve access to safe healthcare by providing a non-invasive alternative for medication administration, with international regulatory approval in over 40 countries.

Updated 2 months ago

Funding

$7.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

NHSM
Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Traditional needle-based drug delivery can cause pain, anxiety, and a risk of needle-stick injuries, leading to poor patient compliance and potential safety concerns for healthcare providers. This method also presents challenges for self-administration and can be a barrier to accessing medication in resource-limited settings.

Solution

NuGen Medical Devices offers needle-free injection technology designed to improve patient comfort and safety while simplifying drug administration. Their devices use a high-pressure jet to deliver medication through the skin without the use of a needle, reducing pain and eliminating the risk of needle-stick injuries. The technology aims to enhance patient compliance, improve access to healthcare, and provide a more convenient and less intimidating method of drug delivery.

Target Audience

The primary target audience includes patients requiring frequent injections, healthcare providers seeking safer and more patient-friendly drug delivery methods, and organizations aiming to improve access to medication in various settings.

Features

  • Needle-free injection technology using high-pressure jet delivery
  • Designed to reduce pain and anxiety associated with traditional injections
  • Eliminates the risk of needle-stick injuries for healthcare providers and patients
  • Suitable for self-administration, improving patient convenience and compliance
  • International regulatory approval in over 40 countries
This profile is AI-generated and may contain inaccuracies.